Skip to content

Venous Thromboembolism in DM1

Incidence and Predictors of Venous Thromboembolism in Myotonic Dystrophy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03141749
Acronym
DM1-VTE
Enrollment
2810
Registered
2017-05-05
Start date
2000-01-31
Completion date
2017-01-31
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis, Myopathy, Myotonic Dystrophy 1, Pulmonary Embolism, Venous Thromboembolism

Brief summary

The risk for venous thromboembolism (VTE) in DM1 and in other inherited myopathies, which can lead to chronic immobilization, are unknown. The purpose of this study is to evaluate incidence of VTE in cohort of patients presenting with DM1 with a comparison to a group of other inheritable myopathies and to a community-based population.

Detailed description

A cohort of more that 2,800 adult patients admitted to our Institutions between January 2000 and November 2014 with genetically proven myopathy will be retrospectively included. Any information relative to their demographic and genetic characteristics, their muscular functional status and the occurrence of VTE will be collected. Statistical analysis will be performed to estimate the incidence of venous thromboembolism in this population, to identify predictors of VTE, and to compare its incidence to a community-based population.

Interventions

None listed

Sponsors

Institut de Myologie, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Genetically proven myopathy * Admission in our institutions from January 2000 to November 2014

Exclusion criteria

* Patient refusal

Design outcomes

Primary

MeasureTime frame
Any episode of pulmonary embolism and/or deep vein thrombosis, diagnosed according to 2011 AHA guidelines on venous thromboembolism management14 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026